The thirtieth Epicentre Scientific Day will take place on Thursday, September 24, 2020.
This year’s program reminds us of several fundamental aspects of Epicentre’s activities. We will present study results and discuss current issues.
During the first morning session, we will discuss HIV with the impact of Dolutegravir, and a tuberculosis (TB) component reviewing studies in Uganda and a synthesis of the results of short treatment multi-drug resistant TB as well as the treatment cases of patients co-infected with Hepatitis C.
In the second session, we will continue with pediatrics by presenting the study on the follow-up of severely acutely malnourished children in Nigeria, the use of MUAC as a criterion for admission and discharge of malnourished children and the follow-up of newborns in Aweil in South Sudan. We will conclude with vaccination against hepatitis B in Côte d'Ivoire.
A round table discussion will summarize the morning sessions, with the aim of highlighting the contribution of social sciences at the core of our scientific activity.
In the afternoon, we will address epidemics with a synthetic description of measles studies related to the impact of Supplementary Immunization Activities (SIA) and mortality studies in DRC, Chad and the Central Africa Republic and still with measles, seroprevalence studies in DRC. We will also discuss the cholera epidemic in Yemen and the typhoid vaccine.
With Ebola, we will address the introduction of vaccines in Uganda and DRC, nosocomial surveys, and the implementation of an algorithm to define the probability of infection, triage, and referral of patients.
To end the day, we will discuss the various issues arising from emerging diseases (including CoVid19) that are currently in the news.
Due to emergencies and circumstances, some presentations may be subject to change. Although well advanced, this program is still provisional.